SCLX Stock Analysis: Buy, Sell, or Hold?
SCLX - Scilex Holding Company Common Stock
$7.81
-0.07 (-0.89%)
▼
5d:
+10.16%
30d:
+5.54%
90d:
+13.02%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When SCLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SCLX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: SCLX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.75
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.19
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SCLX is currently trading at $7.81, which is considered slightly high relative to its 30-day fair value range of $6.72 to $8.16. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.7) compared to its historical average (6.6). At these levels, the market is pricing in 17.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SCLX is in a downtrend. Immediate support is located at $6.11, while resistance sits at $9.74.
Market Sentiment: SCLX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $490.00 (+6174.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SCLX is in a downtrend. Immediate support is located at $6.11, while resistance sits at $9.74.
Market Sentiment: SCLX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $490.00 (+6174.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$6.72 -
$8.16
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 6174.0% below Wall St target ($490.00)
- NEUTRAL: Trading at premium valuation - market expects 17.6% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$6.72 -
$8.16
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$6.11
Resistance Level
$9.75
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.70
Wall Street Target
$490.00
(+6174.0%)
Revenue Growth (YoY)
72.1%
Valuation Premium vs History
+17.6% premium
PE vs Historical
10.7 vs 6.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+17.6%
(market-implied from PE analysis)
1-Year Target
$9.18
(+18%)
2-Year Target
$10.80
(+38%)
3-Year Target
$12.70
(+63%)
3-Yr Target (if PE normalizes)
(PE: 11→7)
PE COMPRESSION
$7.84
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 04, 2026 2:58 AM ET
Data refreshes hourly during market hours. Next update: 3:58 AM
Data refreshes hourly during market hours. Next update: 3:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1223 | 61 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 67 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 69 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$220 | 67 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$254 | 60 HOLD |
